Targeted Multifunctional Multimodal Protein-Shell Microspheres as Cancer Imaging Contrast Agents

PurposeIn this study, protein-shell microspheres filled with a suspension of iron oxide nanoparticles in oil are demonstrated as multimodal contrast agents in magnetic resonance imaging (MRI), magnetomotive optical coherence tomography (MM-OCT), and ultrasound imaging. The development, characterization, and use of multifunctional multimodal microspheres are described for targeted contrast and therapeutic applications.ProceduresA preclinical rat model was used to demonstrate the feasibility of the multimodal multifunctional microspheres as contrast agents in ultrasound, MM-OCT and MRI. Microspheres were functionalized with the RGD peptide ligand, which is targeted to αvβ3 integrin receptors that are over-expressed in tumors and atherosclerotic lesions.ResultsThese microspheres, which contain iron oxide nanoparticles in their cores, can be modulated externally using a magnetic field to create dynamic contrast in MM-OCT. With the presence of iron oxide nanoparticles, these agents also show significant negative T2 contrast in MRI. Using ultrasound B-mode imaging at a frequency of 30 MHz, a marked enhancement of scatter intensity from in vivo rat mammary tumor tissue was observed for these targeted protein microspheres.ConclusionsPreliminary results demonstrate multimodal contrast-enhanced imaging of these functionalized microsphere agents with MRI, MM-OCT, ultrasound imaging, and fluorescence microscopy, including in vivo tracking of the dynamics of these microspheres in real-time using a high-frequency ultrasound imaging system. These targeted oil-filled protein microspheres with the capacity for high drug-delivery loads offer the potential for local delivery of lipophilic drugs under image guidance.

[1]  B. Bouma,et al.  Handbook of Optical Coherence Tomography , 2001 .

[2]  Samuel A. Wickline,et al.  Molecular Imaging of Angiogenesis in Early-Stage Atherosclerosis With &agr;v&bgr;3-Integrin–Targeted Nanoparticles , 2003 .

[3]  Freddy T. Nguyen,et al.  Intraoperative evaluation of breast tumor margins with optical coherence tomography. , 2009, Cancer research.

[4]  Ralph Weissleder,et al.  Multifunctional magnetic nanoparticles for targeted imaging and therapy. , 2008, Advanced drug delivery reviews.

[5]  A. C. Hunter,et al.  Nanomedicine: current status and future prospects , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  Xu Wang,et al.  Application of Nanotechnology in Cancer Therapy and Imaging , 2008, CA: a cancer journal for clinicians.

[7]  J. Schuman,et al.  Optical coherence tomography. , 2000, Science.

[8]  E. Unger,et al.  MRX 501: a novel ultrasound contrast agent with therapeutic properties. , 1998, Academic radiology.

[9]  Alexander Wei,et al.  Magnetomotive contrast for in vivo optical coherence tomography. , 2005, Optics express.

[10]  D. Cheresh,et al.  The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical development. , 1999, The Journal of clinical investigation.

[11]  Daniel L Marks,et al.  Near-infrared dyes as contrast-enhancing agents for spectroscopic optical coherence tomography. , 2004, Optics letters.

[12]  Shelton D Caruthers,et al.  Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles. , 2003, Circulation.

[13]  S. Nie,et al.  In vivo cancer targeting and imaging with semiconductor quantum dots , 2004, Nature Biotechnology.

[14]  Erkki Ruoslahti,et al.  αv Integrins as receptors for tumor targeting by circulating ligands , 1997, Nature Biotechnology.

[15]  Jennifer Kehlet Barton,et al.  Use of microbubbles as an optical coherence tomography contrast agent. , 2002, Academic radiology.

[16]  J. Fujimoto,et al.  Intraoperative assessment of microsurgery with three-dimensional optical coherence tomography. , 1998, Radiology.

[17]  C. Alpers,et al.  Alpha-v beta-3 integrin expression in normal and atherosclerotic artery. , 1995, Circulation research.

[18]  Amy L Oldenburg,et al.  Phase-resolved magnetomotive OCT for imaging nanomolar concentrations of magnetic nanoparticles in tissues. , 2008, Optics express.

[19]  Amy L Oldenburg,et al.  Plasmon-resonant gold nanorods as low backscattering albedo contrast agents for optical coherence tomography. , 2006, Optics express.

[20]  J. Fujimoto,et al.  Optical Coherence Tomography , 1991, LEOS '92 Conference Proceedings.

[21]  Daniel L Marks,et al.  Optical probes and techniques for molecular contrast enhancement in coherence imaging. , 2005, Journal of biomedical optics.

[22]  Amy L Oldenburg,et al.  Imaging magnetically labeled cells with magnetomotive optical coherence tomography. , 2005, Optics letters.

[23]  C. Alpers,et al.  αvβ3 Integrin Expression in Normal and Atherosclerotic Artery , 1995 .

[24]  K. Suslick,et al.  Engineered microsphere contrast agents for optical coherence tomography. , 2003, Optics letters.

[25]  Younan Xia,et al.  Gold nanocages as contrast agents for spectroscopic optical coherence tomography. , 2005, Optics letters.

[26]  R. John,et al.  Dynamics of Magnetic Nanoparticle-Based Contrast Agents in Tissues Tracked Using Magnetomotive Optical Coherence Tomography , 2010, IEEE Journal of Selected Topics in Quantum Electronics.

[27]  R. John,et al.  In vivo magnetomotive optical molecular imaging using targeted magnetic nanoprobes , 2010, Proceedings of the National Academy of Sciences.

[28]  Siavash Yazdanfar,et al.  Molecular contrast in optical coherence tomography by use of a pump-probe technique. , 2003, Optics letters.

[29]  Zhong-gao Gao,et al.  Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. , 2007, Journal of the National Cancer Institute.

[30]  K. Suslick,et al.  Tumor targeting by surface-modified protein microspheres. , 2006, Journal of the American Chemical Society.

[31]  Y Wu,et al.  Acoustically active lipospheres containing paclitaxel: a new therapeutic ultrasound contrast agent. , 1998, Investigative radiology.

[32]  D. Cheresh,et al.  Role of alpha v integrins during angiogenesis. , 2000, Cancer journal.